New blood test aims to catch newborn blood disorder before It's too late
NCT ID NCT07371520
First seen Jan 30, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This study is testing a new way to diagnose hemolytic disease of the newborn (HDN) using a blood test that measures bleeding between mother and baby. Researchers will follow 100 pregnant women at high risk for HDN to see if this test can spot the condition more accurately. The goal is to improve early diagnosis and prevent serious complications like severe jaundice or anemia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOLYTIC DISEASE OF THE NEWBORN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.